Skip to content

The effect of Coriander seed extract on respiratory allergic symptoms

The effect of Coriander seed extract on respiratory allergic symptoms in patients who referred to ENT clinic in Shahrekord

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201206106252N2
Enrollment
72
Registered
2012-07-07
Start date
2012-06-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory allergic. Other seasonal respiratory allergic

Interventions

Intervention 1: The intervention group will be treated by 5 mg of cetirizine pill daily, nasoflow spray one puff in each nostri every 12 hours and patients in this group also will receive Coriander se
Treatment - Drugs
The intervention group will be treated by 5 mg of cetirizine pill daily, nasoflow spray one puff in each nostri every 12 hours and patients in this group also will receive Coriander seed extract in ad
The control group will be treated by 5 mg of cetirizine pill daily and nasoflow spray one puff in each nostril every 12 hours

Sponsors

vice chancellor for research, Shahrekord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclision criteria: patient with respiratory allergic according to ENT specialist idea. Exclusion criteria: patients with hypoglycemia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Running nose. Timepoint: the day 1, 3 and 7 of treatment. Method of measurement: questionnaire.;Nasal irritation. Timepoint: the day 1, 3 and 7 of treatment. Method of measurement: questionnaire.;Severe itching. Timepoint: the day 1, 3 and 7 of treatment. Method of measurement: questionnaire.;Nasal congestion. Timepoint: the day 1, 3 and 7 of treatment. Method of measurement: questionniare.;Red eye. Timepoint: the day 1, 3 and 7 of treatment. Method of measurement: questionnaire.;Itchy eyes. Timepoint: the day 1, 3 and 7 of treatment. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Soroush Amani

Hajar Hospital

samani@skums.ac.ir+98 38 1226 4834

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026